TABLE 3.
Regional measures showing significant differences among participants in the T2DM-MCI, T2DM-N, and HCs groups.
|
Post hoc tests |
||||
| Measurements | p(F) | T2DM-MCI vs. HCs | T2DM-MCI vs. T2DM-N | T2DM-N vs. HCs |
| Nodal degree | ||||
| Hippocampus_L | 0.003 | 0.002 | 0.050 | 0.519 |
| Superior frontal gyrus, orbital part _R | 0.003 | 0.007 | 0.009 | 0.996 |
| Hippocampus_R | 0.003 | 0.002 | 0.252 | 0.132 |
| Inferior temporal gyrus _L | 0.007 | 0.007 | 0.061 | 0.696 |
| Superior occipital gyrus _R | 0.008 | 0.019 | 0.020 | 1.000 |
| Inferior frontal gyrus, orbital part_L | 0.010 | 0.011 | 0.060 | 0.785 |
| Parahippocampal gyrus_L | 0.010 | 0.009 | 0.097 | 0.616 |
| Anterior cingulate gyrus _R | 0.012 | 0.024 | 0.030 | 0.996 |
| Superior frontal gyrus, orbital part _L | 0.015 | 0.039 | 0.026 | 0.986 |
| Supplementary motor area _L | 0.024 | 0.065 | 0.033 | 0.960 |
| Caudate nucleus _R | 0.045 | 0.035 | 0.366 | 0.470 |
| Middle temporal gyrus _R | 0.046 | 0.044 | 0.177 | 0.797 |
| Paracentral lobule _L | 0.046 | 0.035 | 0.401 | 0.438 |
| Nodal efficiency | ||||
| Hippocampus_L | 0.002 | 0.002 | 0.055 | 0.434 |
| Superior frontal gyrus, orbital part _R | 0.003 | 0.005 | 0.012 | 0.962 |
| Hippocampus_R | 0.004 | 0.002 | 0.193 | 0.201 |
| Anterior cingulate gyrus _R | 0.005 | 0.010 | 0.019 | 0.971 |
| Inferior temporal gyrus _L | 0.006 | 0.006 | 0.041 | 0.762 |
| Inferior frontal gyrus, orbital part_L | 0.008 | 0.008 | 0.063 | 0.078 |
| Superior frontal gyrus, orbital part _L | 0.009 | 0.029 | 0.015 | 0.967 |
| Superior occipital gyrus _R | 0.012 | 0.023 | 0.032 | 0.991 |
| Paracentral lobule_R | 0.037 | 0.026 | 0.420 | 0.355 |
| Temporal Pole, middle temporal gyrus_L | 0.045 | 0.039 | 0.237 | 0.994 |
| Olfactory cortex _L | 0.046 | 0.051 | 0.136 | 0.897 |
Comparisons of regional measures among participants in the three groups (p < 0.05, false-positive rate corrected, shown in bold) and post hoc pairwise comparisons (p < 0.05, shown in bold) were performed using Tukey’s t-test. Please refer to Supplementary Figure 1 for more details. T2DM-MCI, type 2 diabetes mellitus patients with mild cognitive impairment; T2DM-N, type 2 diabetes mellitus patients without mild cognitive impairment; HCs, healthy controls; L, left; R, right.